In published radioligand competition assays, tirzepatide binds the human GIP receptor with an affinity comparable to native GIP itself (Ki in the low picomolar range), while its affinity for the human GLP-1 receptor is approximately five-fold lower than that of native GLP-1
This prolonged action helps users feel fuller for longer, controlling weight loss when combined with diet and exercise
Not for human consumption, veterinary use, or clinical administration
Meet Your Injector Marissa Hartman, FNP-C Medical Weight Management, GLP-1 Therapy & B12 I added weight-loss to my menu because too many of my own patients were doing this in the dark ordering medications from sketchy online clinics with no real provider behind them
100% of participants on the 8 mg and 12 mg doses in Phase 2 achieved at least 5% weight loss
Quality monitoring over time Even with a trusted supplier, periodic independent testing remains important